Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Baxter Healthcare Corporation | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective is to understand the best way to place Peritoneal Dialysis (PD) catheters, and the best way to collect data regarding their function in England, Wales and Northern Ireland.
Phase 1: We will carry out a detailed examination of existing returned pilot data with emphasis on data fields with poor data completeness and perform root cause analysis, and assess deficiencies in data field definition to identify improvements to be implemented. We will construct and disseminate electronic survey material to all study centres with targeted visits by the Principle Investigator undertaken. These visits will facilitate insight into local organization of data collection including interaction with designated individuals responsible for data returns. PD training days will be organized with emphasis on clinical practice feedback utilizing data acquired in the initial phases. Hospital Episode Statistics will be linked to existing acquired PD patient information to ensure the accuracy of collected data. An online data acquisition system will be developed to allow direct data entry from centres.
Phase 2: On-going and sustained data acquisition performed on a prospective basis.
Phase 3: Primary data analysis including clinical practice variation in England, Wales and Northern Ireland to identify site specific PD catheter functionality variation. Additionally, patient and site specific characteristics that predict clinical outcomes in PD will be identified and characterised.
Phase 4: Clinical guidelines will be developed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Peritoneal dialysis catheter "survival" (sustained function) at 365 days post-insertion (insertion date) |
| 1 Year |
| Measure | Description | Time Frame |
|---|---|---|
| Time to catheter failure |
| Within 1 Year |
| Missing Data |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All incident patients requiring peritoneal dialysis for end stage renal disease of all etiologies.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Victoria R Briggs, MBBS BMedSci | Sheffield Teaching Hospitals NHS Foundation Trust | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D051436 | Renal Insufficiency, Chronic |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Missing mandatory data fields
| Baseline & 1 Year |
| Mortality (all cause) | Within 1 Year |
| Co-morbid Hospitalization Events | Non-fatal medical events requiring hospitalization, excluding PD related hospitalization | Within 1 Year |
| Infection events not resulting in catheter failure |
| Within 1 Year |
| Leak events not resulting in catheter failure |
| Within 1 Year |
| Modality change | Change of modality from PD to any other form of renal replacement therapy | Within 1 Year |
| Catheter non-usage | Catheters inserted but not used for reasons other than failed initial therapy (e.g. Moncrieff) | Within 1 Year |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |